Anti-NRCAM monoclonal antibody

Anti-NRCAM antibody for FACS & in-vivo assay

Target products collectionGo to NRCAM/NRCAM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0903-Ab-1/ GM-Tg-hg-MP0903-Ab-2Anti-Human NRCAM monoclonal antibodyHuman
GM-Tg-rg-MP0903-Ab-1/ GM-Tg-rg-MP0903-Ab-2Anti-Rat NRCAM monoclonal antibodyRat
GM-Tg-mg-MP0903-Ab-1/ GM-Tg-mg-MP0903-Ab-2Anti-Mouse NRCAM monoclonal antibodyMouse
GM-Tg-cynog-MP0903-Ab-1/ GM-Tg-cynog-MP0903-Ab-2Anti-Cynomolgus/ Rhesus macaque NRCAM monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0903-Ab-1/ GM-Tg-felg-MP0903-Ab-2Anti-Feline NRCAM monoclonal antibodyFeline
GM-Tg-cang-MP0903-Ab-1/ GM-Tg-cang-MP0903-Ab-2Anti-Canine NRCAM monoclonal antibodyCanine
GM-Tg-bovg-MP0903-Ab-1/ GM-Tg-bovg-MP0903-Ab-2Anti-Bovine NRCAM monoclonal antibodyBovine
GM-Tg-equg-MP0903-Ab-1/ GM-Tg-equg-MP0903-Ab-2Anti-Equine NRCAM monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0903-Ab-1/ GM-Tg-hg-MP0903-Ab-2; GM-Tg-rg-MP0903-Ab-1/ GM-Tg-rg-MP0903-Ab-2;
GM-Tg-mg-MP0903-Ab-1/ GM-Tg-mg-MP0903-Ab-2; GM-Tg-cynog-MP0903-Ab-1/ GM-Tg-cynog-MP0903-Ab-2;
GM-Tg-felg-MP0903-Ab-1/ GM-Tg-felg-MP0903-Ab-2; GM-Tg-cang-MP0903-Ab-1/ GM-Tg-cang-MP0903-Ab-2;
GM-Tg-bovg-MP0903-Ab-1/ GM-Tg-bovg-MP0903-Ab-2; GM-Tg-equg-MP0903-Ab-1/ GM-Tg-equg-MP0903-Ab-2
Products NameAnti-NRCAM monoclonal antibody
Formatmab
Target NameNRCAM
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NRCAM benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NRCAM VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0903
    Target NameNRCAM
    Gene ID4897,319504,497815,574228,475881,101093257,534500,100050997
    Gene Symbol and SynonymsBravo,C030017F07Rik,C130076O07Rik,mKIAA0343,NEDNMS,Nr-CAM,NRCAM
    Uniprot AccessionQ92823,P97686
    Uniprot Entry NameNRCAM_HUMAN,NRCAM_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000091129
    Target ClassificationN/A

    The target: NRCAM, gene name: NRCAM, also named as . Cell adhesion molecules (CAMs) are members of the immunoglobulin superfamily. This gene encodes a neuronal cell adhesion molecule with multiple immunoglobulin-like C2-type domains and fibronectin type-III domains. This ankyrin-binding protein is involved in neuron-neuron adhesion and promotes directional signaling during axonal cone growth. This gene is also expressed in non-neural tissues and may play a general role in cell-cell communication via signaling from its intracellular domain to the actin cytoskeleton during directional cell migration. Allelic variants of this gene have been associated with autism and addiction vulnerability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.